Depression Drugs Market 2018-2024
19-Jul-2018 | Number of pages: 172 | Report Id: BMRC MD 122 | Report Format: | Status: Upcoming

Global Depression Drugs Market:Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024

Global Depression Drugs Market 2018-2024

Brandessence Market Research is working on a new report titleGlobal Depression Drugs Market:Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″. Growing in geriatric population, increase in the knowledge about depression, rising number of generic drug market and declining side effects of drugs are projected to boost the growth of Global Depression Drugs Market.

Scope of Global Depression Drugs MarketReports –

 As per WHO, depression is a common mental disorder includes brain that contributes significantly to the global burden of disease. Depression is a serious mood disorder which causes a tenacious feeling of sadness and loss of interest therefore affecting daily routine activities such as sleeping, walking, talking, thinking and eating.Depression is a mental health issue. It is a condition that begins more often in initialstages of adulthood. Also it is more commonly observe in women. Though, anyone at any age may get suffer from depression.Depression affects the brain so drugs that work in the brain called ‘Antidepressant Drugs’. General antidepressants candecrease symptoms, but there are many other options to reduce the depression. Each drug used to treat depression by balancing certain chemicals in brain known as‘Neurotransmitters’. Signs and symptoms of depression differ from individual to individualon the basis of risk factors, individual thinking and lifestyle. It includes sadness, irritability, loss of attention in daily routine activities, feelings of pessimism, guilt, social withdrawal, fatigue, insomnia, loss of appetite, headache, cramps, digestive problems, weight loss or gain, restlessness and suicide attempts.Also, alcoholism and drug abuse may be the signs of depression. Likewise there are different types of depression which has distinctive characteristics such as persistent depressive disorder, perinatal depression disorder, psychotic depression, Seasonal affective disorder and bipolar depression. Depression is also classified based on its severity as mild, moderate and severe. An individual with severe depression can have suicidal thoughts and behaviors. According to 2012estimation by the WHO around 3,000 suicides take place per day, resulting in more than a million deaths each year. Depression can be recurringand can be severely debilitating. Patients with mild depression can be treated with medications but in moderate or severe depressioncases, the patient needs both medication and professional psychotherapy in the form of counseling.

The Global Depression Drugs Market is segmented on the basis of Drug type, Disease Type, Distribution channel,and Geography. On the basis of Drug type Global Depression Drugs Market is divided into Tricyclic Antidepressants, Serotonin-Norepinephrine Inhibitors, Atypical Antipsychotics, Selective Serotonin Reuptake Inhibitors, Benzodiazepines, Tetracyclic Antidepressants, Monoamine Oxidase Inhibitorsand Others.On the basis of Disease Type Global Depression Drugs Marketis divided into Major Depressive Disorder, Schizophrenia, Bipolar I Disorder, Selective Serotonin Reuptake Inhibitor Induced Disorder and other.On the basis of Distribution channel Global Depression Drugs Market is dividedintoHospital pharmacies, Retail pharmacies, Online pharmacies, Clinicsand Research centers.

The regions covered in Global Depression Drugs Marketreport are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Depression Drugs MarketReports –

Global Depression Drugs Market reports cover prominent players like Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Company, Pfizer Inc., AstraZeneca, Allergan USA, Inc., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Sebela Pharmaceutical Inc., Johnson & Johnson, Merck & Co., SK Biopharmaceuticals, Forest Laboratories, Naurex, Actavis, Bristol-Myers Squibb, Intellipharmaceutics, Lundbeck, Allergan, NHU Group,Shionogi, Kanghong Pharma, HUAHAI,Addex Therapeutics,  Alkermes, Cerecor, Dart NeuroScience,  Dr. Reddy’s Laboratories, Edgemont Pharmaceuticals, Euthymics, Fabre Kramer, Gedeon Richter, Intra-Cellular Therapies,Janssen Pharmaceuticals, Lupin, Luye Pharma, MSI Methylation Sciences, Opko Health, Shire, Somerset Pharmaceuticals, Sun Pharmaceutical, Sunovion Pharmaceuticals, Torrent Pharmaceuticals and Valeant Pharmaceuticals.

 Global Depression Drugs Market Dynamics –

Increasing geriatric population globally, growing efficacy and decreasing side effectsofantidepressant drugs are the main factors that drive the Global Depression Drug Market. Also, various government initiatives in increasing awareness on depression, elevating generic drug market, are boosting theGlobal Depression Drugs Market. People transfer from rural to urban areas for job, education, etc. and their suddenly changing lifestyle is one of the key factors driving the growth of Global Depression Drugs Market. Though, lack of awareness among persons regarding depression& its growingoccurrence and threat of expiry of patents would decline the demand for Antidepressant drugs in forecast period.However, non-availability of well-developed healthcare facilities especially in rural and remote areas may decline the growth of the Global Depression Drugs Market.

Growingoccurrence of anxiety and several other depression disorders would offersome growth opportunities for the Global Depression Drugs Market in coming years. Furthermore, increasing investments in research & developments and market expansion would offer growth opportunities for the Global Depression Drugs Market players.

Global Depression Drugs MarketRegional Analysis –

Geographically, North America accounted for the largest market share of around 37.20% in 2016; due to high patient awareness levels regarding availability of various antidepressant drugs for increasing healthcare expenditure and relatively larger number of Research & Development affecting to drug manufacturing and marketing etc. These factors contribute for significant revenue generation from the region. Europe have the second largest share of the Global Depression Drugs Market in 2017, which can be recognized to the increase in research and development activities on depression drugs in the region. Asia-Pacific is to attain the fastest CAGR during the forecast period, owed to increased demand from developing countries such as China, Japan, and Australia. An initiative by the local government to reach self-sufficiency in the manufacturing of Antidepressant drugs and increasing awareness amongst consumers regarding benefits of Antidepressant drug is also likely to boost the growth of Global Depression Drugs Market in the region.

Key Benefits for Global Depression Drugs MarketReports –

  • Global Depression Drugs Marketreport covers in depth historical and forecast analysis.
  • Global Depression Drugs Marketresearch report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Depression Drugs Marketreport helps to identify opportunities in market place.
  • Global Depression Drugs Marketreport covers extensive analysis of emerging trends and competitive landscape.

Global Depression Drugs MarketSegmentation

 Global Depression Drugs Market: By Drug type Analysis

  • Tricyclic Antidepressants
  • Serotonin-Norepinephrine Inhibitors
  • Atypical Antipsychotics
  • Selective Serotonin Reuptake Inhibitors
  • Benzodiazepines
  • Tetracyclic Antidepressants
  • Monoamine Oxidase Inhibitors
  • Other

Global Depression Drugs Market: By Disease TypeAnalysis

  • Major Depressive Disorder
  • Schizophrenia
  • Bipolar I Disorder
  • Selective Serotonin Reuptake Inhibitor Induced Disorder
  • Other

Global Depression Drugs Market: By Distribution channel Analysis

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
  • Clinics
  • Research centres
  • Other

Global Depression Drugs Market: By Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

 

 

 

 

 

 

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Depression Drugs Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Depression Drugs Market:Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Depression Drugs Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Depression Drugs MarketOverview: Quantitative Analysis
    • Global Depression Drugs MarketProduction (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Depression Drugs MarketConsumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Depression Drugs MarketRevenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  2. Chapter –Global Depression Drugs Market: by Drug type
  3. Chapter – Global Depression Drugs Market : byDisease Type
  4. Chapter – Global Depression Drugs Market : byDistribution Channel
  5. Chapter – Global Depression Drugs Market : byManufacturer
    • Global Depression Drugs Market(USD Million), by Manufacturer, 2014 – 2024
    • Global Depression Drugs MarketProduction (K Unit), by Manufacturer, 2014 – 2024
    • Global Depression Drugs MarketConsumption (K Unit), Manufacturer, 2014 – 2024
    • Global Depression Drugs MarketShare (%), by Manufacturer, 2017
    • Global Depression Drugs MarketPrice (USD/Unit), by Manufacturer, 2014 – 2024
    • Global Depression Drugs MarketRevenue Growth Rate (%), by Manufacturer, 2014 – 2024
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  6. Chapter -Global Depression Drugs Market: Regional Analysis
    • North America
    • North America Global Depression Drugs Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Depression Drugs Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Depression Drugs Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Depression Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Depression Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North AmericaGlobal Depression Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  7. Chapter – Company Profiles
    • Actavis
      • Overview
      • Financials
      • Product portfolio
      • Global Depression Drugs MarketRevenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
      • Global Depression Drugs MarketShare (%), 2014 – 2017
      • Business strategy
      • Recent developments
    • Addex Therapeutics
    • Alkermes
    • Allergan Inc.
    • AstraZeneca
    • Bristol-Myers Squibb
    • Cerecor
    • Dart NeuroScience
    • Reddy’s Laboratories
    • Edgemont Pharmaceuticals
    • Eli Lilly and Company
    • Euthymics
    • Fabre Kramer
    • Forest Laboratories
    • Gedeon Richter
    • HUAHAI
    • Intellipharmaceutics
    • Intra-Cellular Therapies
    • Janssen Pharmaceuticals
    • Johnson & Johnson
    • Kanghong Pharma
    • Lundbeck
    • Lupin
    • Luye Pharma
    • Merck & Co.
    • MSI Methylation Sciences
    • Naurex
    • NHU Group
    • Novartis AG, GlaxoSmithKline
    • Opko Health
    • Otsuka Pharmaceutical Co. Ltd.
    • Pfizer Inc.
    • Sebela Pharmaceutical Inc.
    • Shionogi
    • Shire
    • SK Biopharmaceuticals
    • Somerset Pharmaceuticals
    • Sun Pharmaceutical
    • Sunovion Pharmaceuticals
    • Takeda Pharmaceutical Company Ltd
    • Torrent Pharmaceuticals
    • Valeant Pharmaceuticals
    • Others
  8. Chapter – Market Research and Findings

 

 

Global Depression Drugs Market 2018-2024

Our 172 pages report provides 85tables, 75 charts and 65 graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Depression Drugs Market
  • To receive forecasts of Global Depression Drugs Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
  • To discover the views of experts in theGlobal Depression Drugs Market sector
  • To determine the forces and factor that influencesthe market forGlobal Depression Drugs Market: drivers, restraints, opportunities and threats
  • To find out where the Global Depression Drugs Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

Global Depression Drugs Market: By Region Analysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Production

(K Unit)

North AmericaXXXXXXXXXXXX
EuropeXXXXXXXXXXXX
Asia PacificXXXXXXXXXXXX
Latin AmericaXXXXXXXXXXXX
Middle East & AfricaXXXXXXXXXXXX
GlobalXXXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Depression Drugs Market: By Drug typeAnalysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Production

(K Unit)

 XXXXXXXXXXXX
Tricyclic AntidepressantsXXXXXXXXXXXX
Serotonin-Norepinephrine InhibitorsXXXXXXXXXXXX
Atypical AntipsychoticsXXXXXXXXXXXX
Selective Serotonin Reuptake InhibitorsXXXXXXXXXXXX
BenzodiazepinesXXXXXXXXXXXX
Tetracyclic AntidepressantsXXXXXXXXXXXX
Monoamine Oxidase Inhibitors XXXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Depression Drugs Market: By Disease type Analysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Production

(K Unit)

Major Depressive DisorderXXXXXXXXXXXX
SchizophreniaXXXXXXXXXXXX
Bipolar I DisorderXXXXXXXXXXXX
Selective Serotonin Reuptake Inhibitor Induced Disorder XXXXXXXXXXXX
OtherXXXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Depression Drugs Market: By Distribution Channel Analysis

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Hospital pharmaciesXXXXXXXXXX
Retail pharmaciesXXXXXXXXXX
Online pharmaciesXXXXXXXXXX
Clinics XXXXXXXXXX
Research centresXXXXXXXXXX
OtherXXXXXXXXXX

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

This report features news, insights, the latest developments and an in depth survey ofGlobal Depression Drugs Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

Companies Mentioned in This Report,

  • Actavis
  • Addex Therapeutics
  • Alkermes
  • Allergan Inc.
  • AstraZeneca
  • Bristol-Myers Squibb
  • Cerecor
  • Dart NeuroScience
  • Reddy’s Laboratories
  • Edgemont Pharmaceuticals
  • Eli Lilly and Company
  • Euthymics
  • Fabre Kramer
  • Forest Laboratories
  • Gedeon Richter
  • HUAHAI
  • Intellipharmaceutics
  • Intra-Cellular Therapies
  • Janssen Pharmaceuticals
  • Johnson & Johnson
  • Kanghong Pharma
  • Lundbeck
  • Lupin
  • Luye Pharma
  • Merck & Co.
  • MSI Methylation Sciences
  • Naurex
  • NHU Group
  • Novartis AG, GlaxoSmithKline
  • Opko Health
  • Otsuka Pharmaceutical Co.Ltd.
  • Pfizer Inc.
  • Sebela Pharmaceutical Inc.
  • Shionogi
  • Shire
  • SK Biopharmaceuticals
  • Somerset Pharmaceuticals
  • Sun Pharmaceutical
  • Sunovion Pharmaceuticals
  • Takeda Pharmaceutical Company Ltd
  • Torrent Pharmaceuticals
  • Valeant Pharmaceuticals
  • Others

 

 

 

 

  • Actavis
  • Addex Therapeutics
  • Alkermes
  • Allergan Inc.
  • AstraZeneca
  • Bristol-Myers Squibb
  • Cerecor
  • Dart NeuroScience
  • Reddy’s Laboratories
  • Edgemont Pharmaceuticals
  • Eli Lilly and Company
  • Euthymics
  • Fabre Kramer
  • Forest Laboratories
  • Gedeon Richter
  • HUAHAI
  • Intellipharmaceutics
  • Intra-Cellular Therapies
  • Janssen Pharmaceuticals
  • Johnson & Johnson
  • Kanghong Pharma
  • Lundbeck
  • Lupin
  • Luye Pharma
  • Merck & Co.
  • MSI Methylation Sciences
  • Naurex
  • NHU Group
  • Novartis AG, GlaxoSmithKline
  • Opko Health
  • Otsuka Pharmaceutical Co.Ltd.
  • Pfizer Inc.
  • Sebela Pharmaceutical Inc.
  • Shionogi
  • Shire
  • SK Biopharmaceuticals
  • Somerset Pharmaceuticals
  • Sun Pharmaceutical
  • Sunovion Pharmaceuticals
  • Takeda Pharmaceutical Company Ltd
  • Torrent Pharmaceuticals
  • Valeant Pharmaceuticals
  • Others